Healthcare >> CEO Interviews >> September 11, 2014
Neil Lyons joined Cleveland BioLabs, Inc., as Chief Financial Officer in 2011. He has more than 30 years of experience in operations, finance, strategy, SEC compliance, information systems and corporate governance in both public and private companies. Prior to joining the company, Mr. Lyons served as Chief Financial Officer, Secretary and Treasurer of RegeneRx Biopharmaceuticals, Inc., where he led several financial transactions, influenced clinical/corporate strategy, identified and captured government grant opportunities, directed investor relations, developed financial models, and implemented investment strategies and employee benefit programs. From 2003 until 2005, Mr. Lyons founded and was the Principal of Ironbridge Consulting, a firm providing financial management advisory services, including the implementation of Sarbanes-Oxley Act compliance procedures, to businesses in the Washington, D.C., metro area. From 1998 until 2003, he was the Vice President, Finance of SkyBridge Limited Partnership, an international satellite broadband startup affiliated with Alcatel, where he secured significant amounts of capital, and was an active participant in acquisition and joint venture activities. Prior to that, he served in various positions at Bell Atlantic — now Verizon — and HFS, Inc., a major Department of Defense contractor. Mr. Lyons started his career practicing public accounting with Deloitte and Arthur Young. Mr. Lyons is a certified public accountant and received a Bachelor of Science degree in accounting, magna cum laude, from Florida Southern College. Profile
TWST: Can you provide an overview of the company and describe your core technology?
Mr. Lyons: Certainly. Our key focus is oncology, but we also have a pivotal-stage radiation